APIs and Its Intermidiates

Active Pharmaceutical Ingredients (APIs)

At GJC Pharmaceuticals Pvt Ltd, we supply high-quality Active Pharmaceutical Ingredients (APIs) manufactured under strict quality standards to support pharmaceutical formulation worldwide. Our APIs are produced following WHO-GMP compliant processes, ensuring consistency, purity, and reliability for pharmaceutical manufacturers.

We are committed to delivering high-purity APIs for diabetes, metabolic disorders, and innovative therapeutic segments, supported by documentation and export compliance.

Sr.No. Project
1 Semaglutide 
2 Tirzepatide
3 Retatrutide
4 Dapagliflozin

Semaglutide API

Semaglutide is a GLP-1 receptor agonist widely used for the treatment of Type-2 Diabetes Mellitus and chronic weight management. It improves glycemic control by enhancing insulin secretion, reducing glucagon release, and slowing gastric emptying.

Key Features

  • High purity pharmaceutical grade

  • Suitable for peptide formulation development

  • Stable and consistent batch quality

  • Manufactured under controlled conditions

Applications

  • Anti-diabetic formulations

  • Obesity management medicines

  • GLP-1 receptor agonist based therapies

Available Form

  • Lyophilized powder API

  • Custom packaging as per client requirements

 

Tirzepatide API

Tirzepatide is a next-generation peptide used in the treatment of Type-2 Diabetes and obesity. It functions as a dual GIP and GLP-1 receptor agonist, offering improved metabolic control and significant weight reduction.

Key Features

  • Advanced peptide API

  • High-purity manufacturing

  • Reliable supply chain for pharmaceutical development

  • Batch-to-batch consistency

Applications

  • Anti-diabetic therapies

  • Obesity and metabolic disorder treatments

  • Innovative peptide-based drug development

Available Form

  • Lyophilized peptide powder

  • Export-ready packaging

 

Retatrutide API

Retatrutide is an emerging investigational peptide designed for the management of obesity and metabolic disorders. It acts as a triple receptor agonist (GLP-1, GIP, and glucagon receptors), offering promising therapeutic benefits in metabolic disease treatment.

Key Features

  • Innovative metabolic therapy API

  • High purity peptide manufacturing

  • Suitable for pharmaceutical research and formulation

Applications

  • Obesity management research

  • Metabolic disease therapeutics

  • Next-generation peptide drug development

Available Form

  • Lyophilized peptide powder

 

Dapagliflozin API

Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor used in the management of Type-2 Diabetes, heart failure, and chronic kidney disease. It lowers blood glucose by promoting glucose excretion through urine.

Key Features

  • High purity pharmaceutical API

  • Reliable quality standards

  • Suitable for tablet and capsule formulations

  • Stable and consistent supply

Applications

  • Anti-diabetic formulations

  • Cardiovascular disease therapy

  • Renal disease management

Available Form

  • Crystalline powder